Skip to main content
Erschienen in: World Journal of Pediatrics 1/2022

04.01.2022 | Review Article

Developmental hemostasis in the neonatal period

verfasst von: Vicente Rey y Formoso, Ricardo Barreto Mota, Henrique Soares

Erschienen in: World Journal of Pediatrics | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The hemostatic system is complex and evolves continuously since gestation and well into the adult years, in a process known as “developmental hemostasis.”

Data sources

A comprehensive review was performed after an extensive literature search on PubMed/MEDLINE concerning developmental hemostasis during the neonatal period. Relevant cross references were also included.

Results

Although part of a system, each component of the hemostatic system evolves differently, with many displaying both quantitative and qualitative age-related differences. This leads to drastic disparities between the coagulation system of neonates and both other children’s and adults’, while still maintaining a generally balanced and physiological hemostasis. The motives behind this process remain to be fully elucidated but may be, at least in part, related to non-hemostatic factors.

Conclusions

Knowledge regarding “developmental hemostasis” is essential for everyone caring for newborns or even children in general and in this review, we describe each hemostatic system component’s neonatal characteristics and age-related progression as well as explore some of the possible physiological motives behind the process.
Literatur
1.
Zurück zum Zitat Ignjatovic V, Mertyn E, Monagle P. The coagulation system in children: developmental and pathophysiological considerations. Semin Thromb Hemost. 2011;37:723–9.PubMedCrossRef Ignjatovic V, Mertyn E, Monagle P. The coagulation system in children: developmental and pathophysiological considerations. Semin Thromb Hemost. 2011;37:723–9.PubMedCrossRef
2.
Zurück zum Zitat Campbell SE, Bolton-Maggs PH. Congenital and acquired bleeding disorders in infancy. Early Hum Dev. 2015;91:637–42.PubMedCrossRef Campbell SE, Bolton-Maggs PH. Congenital and acquired bleeding disorders in infancy. Early Hum Dev. 2015;91:637–42.PubMedCrossRef
4.
Zurück zum Zitat Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev. 2010;24:63–8.PubMedCrossRef Monagle P, Ignjatovic V, Savoia H. Hemostasis in neonates and children: pitfalls and dilemmas. Blood Rev. 2010;24:63–8.PubMedCrossRef
5.
Zurück zum Zitat Guzzetta NA, Miller BE. Principles of hemostasis in children: models and maturation. Paediatr Anaesth. 2011;21:3–9.PubMedCrossRef Guzzetta NA, Miller BE. Principles of hemostasis in children: models and maturation. Paediatr Anaesth. 2011;21:3–9.PubMedCrossRef
6.
Zurück zum Zitat Jaffray J, Young G. Developmental hemostasis: clinical implications from the fetus to the adolescent. Pediatr Clin N Am. 2013;60:1407–17.CrossRef Jaffray J, Young G. Developmental hemostasis: clinical implications from the fetus to the adolescent. Pediatr Clin N Am. 2013;60:1407–17.CrossRef
7.
Zurück zum Zitat Kulkarni AA, Osmond M, Bapir M, Riddell A, Smith C, Lee CA, et al. The effect of labour on the coagulation system in the term neonate. Haemophilia. 2013;19:533–8.PubMedCrossRef Kulkarni AA, Osmond M, Bapir M, Riddell A, Smith C, Lee CA, et al. The effect of labour on the coagulation system in the term neonate. Haemophilia. 2013;19:533–8.PubMedCrossRef
8.
Zurück zum Zitat Monagle P, Massicotte P. Developmental haemostasis: secondary haemostasis. Semin Fetal Neonatal Med. 2011;16:294–300.PubMedCrossRef Monagle P, Massicotte P. Developmental haemostasis: secondary haemostasis. Semin Fetal Neonatal Med. 2011;16:294–300.PubMedCrossRef
9.
Zurück zum Zitat Strauss T, Sidlik-Muskatel R, Kenet G. Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med. 2011;16:301–4.PubMedCrossRef Strauss T, Sidlik-Muskatel R, Kenet G. Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med. 2011;16:301–4.PubMedCrossRef
10.
Zurück zum Zitat Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Semin Perinatol. 1997;21:70–85.PubMedCrossRef Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Semin Perinatol. 1997;21:70–85.PubMedCrossRef
11.
Zurück zum Zitat Neary E, McCallion N, Kevane B, Cotter M, Egan K, Regan I, et al. Coagulation indices in very preterm infants from cord blood and postnatal samples. J Thromb Haemost. 2015;13:2021–30.PubMedCrossRef Neary E, McCallion N, Kevane B, Cotter M, Egan K, Regan I, et al. Coagulation indices in very preterm infants from cord blood and postnatal samples. J Thromb Haemost. 2015;13:2021–30.PubMedCrossRef
12.
Zurück zum Zitat Nowak-Göttl U, Limperger V, Bauer A, Kowalski D, Kenet G. Bleeding issues in neonates and infants-update 2015. Thromb Res. 2015;135(Suppl 1):S41–3.PubMedCrossRef Nowak-Göttl U, Limperger V, Bauer A, Kowalski D, Kenet G. Bleeding issues in neonates and infants-update 2015. Thromb Res. 2015;135(Suppl 1):S41–3.PubMedCrossRef
13.
Zurück zum Zitat Bhat R, Monagle P. The preterm infant with thrombosis. Arch Dis Child Fetal Neonatal Ed. 2012;97:F423–8.PubMedCrossRef Bhat R, Monagle P. The preterm infant with thrombosis. Arch Dis Child Fetal Neonatal Ed. 2012;97:F423–8.PubMedCrossRef
14.
Zurück zum Zitat Israels SJ, Rand ML, Michelson AD. Neonatal platelet function. Semin Thromb Hemost. 2003;29:363–72.PubMedCrossRef Israels SJ, Rand ML, Michelson AD. Neonatal platelet function. Semin Thromb Hemost. 2003;29:363–72.PubMedCrossRef
15.
Zurück zum Zitat Lippi G, Franchini M, Montagnana M, Guidi GC. Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thromb Hemost. 2007;33:816–20.PubMedCrossRef Lippi G, Franchini M, Montagnana M, Guidi GC. Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thromb Hemost. 2007;33:816–20.PubMedCrossRef
16.
Zurück zum Zitat Lippi G, Salvagno GL, Rugolotto S, Chiaffoni GP, Padovani EM, Franchini M, et al. Routine coagulation tests in newborn and young infants. J Thromb Thrombolysis. 2007;24:153–5.PubMedCrossRef Lippi G, Salvagno GL, Rugolotto S, Chiaffoni GP, Padovani EM, Franchini M, et al. Routine coagulation tests in newborn and young infants. J Thromb Thrombolysis. 2007;24:153–5.PubMedCrossRef
17.
Zurück zum Zitat Monagle P, Barnes C, Ignjatovic V, Furmedge J, Newall F, Chan A, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95:362–72.PubMedCrossRef Monagle P, Barnes C, Ignjatovic V, Furmedge J, Newall F, Chan A, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95:362–72.PubMedCrossRef
18.
Zurück zum Zitat Jaffray J, Young G, Ko RH. The bleeding newborn: a review of presentation, diagnosis, and management. Semin Fetal Neonatal Med. 2016;21:44–9.PubMedCrossRef Jaffray J, Young G, Ko RH. The bleeding newborn: a review of presentation, diagnosis, and management. Semin Fetal Neonatal Med. 2016;21:44–9.PubMedCrossRef
19.
Zurück zum Zitat Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70:165–72.PubMedCrossRef Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70:165–72.PubMedCrossRef
20.
Zurück zum Zitat Diaz-Miron J, Miller J, Vogel AM. Neonatal hematology. Semin Pediatr Surg. 2013;22:199–204.PubMedCrossRef Diaz-Miron J, Miller J, Vogel AM. Neonatal hematology. Semin Pediatr Surg. 2013;22:199–204.PubMedCrossRef
21.
Zurück zum Zitat Goldenberg NA, Manco-Johnson MJ. Pediatric hemostasis and use of plasma components. Best Pract Res Clin Haematol. 2006;19:143–55.PubMedCrossRef Goldenberg NA, Manco-Johnson MJ. Pediatric hemostasis and use of plasma components. Best Pract Res Clin Haematol. 2006;19:143–55.PubMedCrossRef
22.
Zurück zum Zitat Bernhard H, Rosenkranz A, Petritsch M, Köfeler H, Rehak T, Novak M, et al. Phospholipid content, expression and support of thrombin generation of neonatal platelets. Acta Paediatr. 2009;98:251–5.PubMedCrossRef Bernhard H, Rosenkranz A, Petritsch M, Köfeler H, Rehak T, Novak M, et al. Phospholipid content, expression and support of thrombin generation of neonatal platelets. Acta Paediatr. 2009;98:251–5.PubMedCrossRef
23.
Zurück zum Zitat Haley KM, Recht M, McCarty OJ. Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system. Pediatr Res. 2014;76:230–7.PubMedPubMedCentralCrossRef Haley KM, Recht M, McCarty OJ. Neonatal platelets: mediators of primary hemostasis in the developing hemostatic system. Pediatr Res. 2014;76:230–7.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Salonvaara M, Riikonen P, Kekomäki R, Vahtera E, Mahlamäki E, Halonen P, et al. Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants. Arch Dis Child Fetal Neonatal Ed. 2003;88:F319–23.PubMedPubMedCentralCrossRef Salonvaara M, Riikonen P, Kekomäki R, Vahtera E, Mahlamäki E, Halonen P, et al. Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants. Arch Dis Child Fetal Neonatal Ed. 2003;88:F319–23.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Bauman ME, Cheung PY, Massicotte MP. Hemostasis and platelet dysfunction in asphyxiated neonates. J Pediatr. 2011;158(2 Suppl):e35–9.PubMedCrossRef Bauman ME, Cheung PY, Massicotte MP. Hemostasis and platelet dysfunction in asphyxiated neonates. J Pediatr. 2011;158(2 Suppl):e35–9.PubMedCrossRef
26.
Zurück zum Zitat Faraoni D, O’Leary JD. Understanding developmental hemostasis through the use of viscoelastic tests of whole blood coagulation. Minerva Anestesiol. 2017;83:347–9.PubMedCrossRef Faraoni D, O’Leary JD. Understanding developmental hemostasis through the use of viscoelastic tests of whole blood coagulation. Minerva Anestesiol. 2017;83:347–9.PubMedCrossRef
27.
Zurück zum Zitat Konstantinidi A, Sokou R, Parastatidou S, Lampropoulou K, Katsaras G, Boutsikou T, et al. Clinical application of thromboelastography/thromboelastometry (TEG/TEM) in the neonatal population: a narrative review. Semin Thromb Hemost. 2019;45:449–57.PubMedCrossRef Konstantinidi A, Sokou R, Parastatidou S, Lampropoulou K, Katsaras G, Boutsikou T, et al. Clinical application of thromboelastography/thromboelastometry (TEG/TEM) in the neonatal population: a narrative review. Semin Thromb Hemost. 2019;45:449–57.PubMedCrossRef
28.
Zurück zum Zitat Sokou R, Konstantinidi A, Stefanaki C, Tsantes AG, Parastatidou S, Lampropoulou K, et al. Thromboelastometry: studying hemostatic profile in small for gestational age neonates-a pilot observational study. Eur J Pediatr. 2019;178:551–7.PubMedCrossRef Sokou R, Konstantinidi A, Stefanaki C, Tsantes AG, Parastatidou S, Lampropoulou K, et al. Thromboelastometry: studying hemostatic profile in small for gestational age neonates-a pilot observational study. Eur J Pediatr. 2019;178:551–7.PubMedCrossRef
29.
Zurück zum Zitat Mitsiakos G, Karametou M, Gkampeta A, Karali C, Papathanasiou AE, Papacharalambous E, et al. Effectiveness and safety of 4-factor prothrombin complex concentrate (4PCC) in neonates with intractable bleeding or severe coagulation disturbances: a retrospective study of 37 cases. J Pediatr Hematol Oncol. 2019;41:e135–40.PubMedCrossRef Mitsiakos G, Karametou M, Gkampeta A, Karali C, Papathanasiou AE, Papacharalambous E, et al. Effectiveness and safety of 4-factor prothrombin complex concentrate (4PCC) in neonates with intractable bleeding or severe coagulation disturbances: a retrospective study of 37 cases. J Pediatr Hematol Oncol. 2019;41:e135–40.PubMedCrossRef
30.
Zurück zum Zitat Guzzetta NA, Williams GD. Current use of factor concentrates in pediatric cardiac anesthesia. Paediatr Anaesth. 2017;27:678–87.PubMedCrossRef Guzzetta NA, Williams GD. Current use of factor concentrates in pediatric cardiac anesthesia. Paediatr Anaesth. 2017;27:678–87.PubMedCrossRef
31.
Zurück zum Zitat Del Vecchio A, Sola MC. Performing and interpreting the bleeding time in the neonatal intensive care unit. Clin Perinatol. 2000;27:643–54.PubMedCrossRef Del Vecchio A, Sola MC. Performing and interpreting the bleeding time in the neonatal intensive care unit. Clin Perinatol. 2000;27:643–54.PubMedCrossRef
32.
33.
Zurück zum Zitat Will A. Neonatal haemostasis and the management of neonatal thrombosis. Br J Haematol. 2015;169:324–32.PubMedCrossRef Will A. Neonatal haemostasis and the management of neonatal thrombosis. Br J Haematol. 2015;169:324–32.PubMedCrossRef
34.
Zurück zum Zitat Schott NJ, Emery SP, Garbee C, Waters J. Thromboelastography in term neonates. J Matern Fetal Neonatal Med. 2018;31:2599–604.PubMedCrossRef Schott NJ, Emery SP, Garbee C, Waters J. Thromboelastography in term neonates. J Matern Fetal Neonatal Med. 2018;31:2599–604.PubMedCrossRef
35.
Zurück zum Zitat Nacoti M, Corbella D, Fazzi F, Rapido F, Bonanomi E. Coagulopathy and transfusion therapy in pediatric liver transplantation. World J Gastroenterol. 2016;22:2005–23.PubMedPubMedCentralCrossRef Nacoti M, Corbella D, Fazzi F, Rapido F, Bonanomi E. Coagulopathy and transfusion therapy in pediatric liver transplantation. World J Gastroenterol. 2016;22:2005–23.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Haidl H, Zöhrer E, Pohl S, Leschnik B, Weiss EC, Gallistl S, et al. New insights into neonatal coagulation: normal clot formation despite lower intra-clot thrombin levels. Pediatr Res. 2019;86:719–24.PubMedCrossRef Haidl H, Zöhrer E, Pohl S, Leschnik B, Weiss EC, Gallistl S, et al. New insights into neonatal coagulation: normal clot formation despite lower intra-clot thrombin levels. Pediatr Res. 2019;86:719–24.PubMedCrossRef
37.
Zurück zum Zitat Tesfamariam B. Distinct characteristics of neonatal platelet reactivity. Pharmacol Res. 2017;123:1–9.PubMedCrossRef Tesfamariam B. Distinct characteristics of neonatal platelet reactivity. Pharmacol Res. 2017;123:1–9.PubMedCrossRef
38.
Zurück zum Zitat Van Cott EM, Grabowski EF. Vascular hemostasis in flowing blood in children. Semin Thromb Hemost. 1998;24:583–90.PubMedCrossRef Van Cott EM, Grabowski EF. Vascular hemostasis in flowing blood in children. Semin Thromb Hemost. 1998;24:583–90.PubMedCrossRef
39.
Zurück zum Zitat Sola-Visner M, Bercovitz RS. Neonatal platelet transfusions and future areas of research. Transfus Med Rev. 2016;30:183–8.PubMedCrossRef Sola-Visner M, Bercovitz RS. Neonatal platelet transfusions and future areas of research. Transfus Med Rev. 2016;30:183–8.PubMedCrossRef
40.
Zurück zum Zitat Schlagenhauf A, Schweintzger S, Birner-Gruenberger R, Leschnik B, Muntean W. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets. 2010;21:641–7.PubMedCrossRef Schlagenhauf A, Schweintzger S, Birner-Gruenberger R, Leschnik B, Muntean W. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets. 2010;21:641–7.PubMedCrossRef
41.
Zurück zum Zitat Sidlik R, Strauss T, Morag I, Shenkman B, Tamarin I, Lubetsky A, et al. Assessment of functional fibrinolysis in cord blood using modified thromboelastography. Pediatr Blood Cancer. 2016;63:839–43.PubMedCrossRef Sidlik R, Strauss T, Morag I, Shenkman B, Tamarin I, Lubetsky A, et al. Assessment of functional fibrinolysis in cord blood using modified thromboelastography. Pediatr Blood Cancer. 2016;63:839–43.PubMedCrossRef
42.
Zurück zum Zitat Punzalan RC, Gottschall JL. Use and future investigations of recombinant and plasma-derived coagulation and anticoagulant products in the neonate. Transfus Med Rev. 2016;30:189–96.PubMedCrossRef Punzalan RC, Gottschall JL. Use and future investigations of recombinant and plasma-derived coagulation and anticoagulant products in the neonate. Transfus Med Rev. 2016;30:189–96.PubMedCrossRef
43.
Zurück zum Zitat Pal S, Curley A, Stanworth SJ. Interpretation of clotting tests in the neonate. Arch Dis Child Fetal Neonatal Ed. 2015;100:F270–4.PubMedCrossRef Pal S, Curley A, Stanworth SJ. Interpretation of clotting tests in the neonate. Arch Dis Child Fetal Neonatal Ed. 2015;100:F270–4.PubMedCrossRef
44.
Zurück zum Zitat Mitsiakos G, Papaioannou G, Papadakis E, Chatziioannidis E, Giougi E, Karagianni P, et al. Haemostatic profile of full-term, healthy, small for gestational age neonates. Thromb Res. 2009;124:288–91.PubMedCrossRef Mitsiakos G, Papaioannou G, Papadakis E, Chatziioannidis E, Giougi E, Karagianni P, et al. Haemostatic profile of full-term, healthy, small for gestational age neonates. Thromb Res. 2009;124:288–91.PubMedCrossRef
45.
Zurück zum Zitat Mitsiakos G, Giougi E, Chatziioannidis I, Karagianni P, Papadakis E, Tsakalidis C, et al. Haemostatic profile of healthy premature small for gestational age neonates. Thromb Res. 2010;126:103–6.PubMedCrossRef Mitsiakos G, Giougi E, Chatziioannidis I, Karagianni P, Papadakis E, Tsakalidis C, et al. Haemostatic profile of healthy premature small for gestational age neonates. Thromb Res. 2010;126:103–6.PubMedCrossRef
47.
Zurück zum Zitat Raffaeli G, Tripodi A, Cavallaro G, Cortesi V, Scalambrino E, Pesenti N, et al. Thromboelastographic profiles of healthy very low birthweight infants serially during their first month. Arch Dis Child Fetal Neonatal Ed. 2020;105:412–8.PubMedCrossRef Raffaeli G, Tripodi A, Cavallaro G, Cortesi V, Scalambrino E, Pesenti N, et al. Thromboelastographic profiles of healthy very low birthweight infants serially during their first month. Arch Dis Child Fetal Neonatal Ed. 2020;105:412–8.PubMedCrossRef
48.
Zurück zum Zitat Revel-Vilk S. The conundrum of neonatal coagulopathy. Hematology Am Soc Hematol Educ Program. 2012;2012:450–4.PubMedCrossRef Revel-Vilk S. The conundrum of neonatal coagulopathy. Hematology Am Soc Hematol Educ Program. 2012;2012:450–4.PubMedCrossRef
49.
Zurück zum Zitat Ghirardello S, Raffaeli G, Scalambrino E, Chantarangkul V, Cavallaro G, Artoni A, et al. The intra-assay reproducibility of thromboelastography in very low birth weight infants. Early Hum Dev. 2018;127:48–52.PubMedCrossRef Ghirardello S, Raffaeli G, Scalambrino E, Chantarangkul V, Cavallaro G, Artoni A, et al. The intra-assay reproducibility of thromboelastography in very low birth weight infants. Early Hum Dev. 2018;127:48–52.PubMedCrossRef
50.
Zurück zum Zitat Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958–65.PubMedCrossRef Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958–65.PubMedCrossRef
51.
Zurück zum Zitat Del Vecchio A, Motta M, Romagnoli C. Neonatal platelet function. Clin Perinatol. 2015;42:625–38.PubMedCrossRef Del Vecchio A, Motta M, Romagnoli C. Neonatal platelet function. Clin Perinatol. 2015;42:625–38.PubMedCrossRef
53.
Zurück zum Zitat Mirabella L, Cotoia A, Colacicco G, Tullo L, Salatto P, Mollica G, et al. Reference values for coagulation assessment in full-term newborns. Minerva Anestesiol. 2017;83:369–74.PubMedCrossRef Mirabella L, Cotoia A, Colacicco G, Tullo L, Salatto P, Mollica G, et al. Reference values for coagulation assessment in full-term newborns. Minerva Anestesiol. 2017;83:369–74.PubMedCrossRef
54.
Zurück zum Zitat Weiss HJ, Lages B. Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood. 1988;71:629–35.PubMedCrossRef Weiss HJ, Lages B. Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood. 1988;71:629–35.PubMedCrossRef
55.
Zurück zum Zitat Hassan HJ, Leonardi A, Chelucci C, Mattia G, Macioce G, Guerriero R, et al. Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Blood. 1990;76:1158–64.PubMedCrossRef Hassan HJ, Leonardi A, Chelucci C, Mattia G, Macioce G, Guerriero R, et al. Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Blood. 1990;76:1158–64.PubMedCrossRef
56.
Zurück zum Zitat Acharya SS. Rare bleeding disorders in children: identification and primary care management. Pediatrics. 2013;132:882–92.PubMedCrossRef Acharya SS. Rare bleeding disorders in children: identification and primary care management. Pediatrics. 2013;132:882–92.PubMedCrossRef
57.
Zurück zum Zitat Israels SJ, Cheang T, McMillan-Ward EM, Cheang M. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr. 2001;138:116–9.PubMedCrossRef Israels SJ, Cheang T, McMillan-Ward EM, Cheang M. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr. 2001;138:116–9.PubMedCrossRef
58.
Zurück zum Zitat Radicioni M, Mezzetti D, Del Vecchio A, Motta M. Thromboelastography: might work in neonatology too? J Matern Fetal Neonatal Med. 2012;25(Suppl 4):18–21.PubMed Radicioni M, Mezzetti D, Del Vecchio A, Motta M. Thromboelastography: might work in neonatology too? J Matern Fetal Neonatal Med. 2012;25(Suppl 4):18–21.PubMed
59.
Zurück zum Zitat Thornburg C, Pipe S. Neonatal thromboembolic emergencies. Semin Fetal Neonatal Med. 2006;11:198–206.PubMedCrossRef Thornburg C, Pipe S. Neonatal thromboembolic emergencies. Semin Fetal Neonatal Med. 2006;11:198–206.PubMedCrossRef
60.
Zurück zum Zitat Jaggers J, Lawson JH. Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies. Ann Thorac Surg. 2006;81:S2360–6.PubMedCrossRef Jaggers J, Lawson JH. Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies. Ann Thorac Surg. 2006;81:S2360–6.PubMedCrossRef
61.
Zurück zum Zitat Maroney SA, Peterson JA, Zwifelhofer W, Martinez ND, Yan K, Bercovitz RS, et al. Plasma proteolytic cascade activation during neonatal cardiopulmonary bypass surgery. Thromb Haemost. 2018;118:1545–55.PubMedPubMedCentralCrossRef Maroney SA, Peterson JA, Zwifelhofer W, Martinez ND, Yan K, Bercovitz RS, et al. Plasma proteolytic cascade activation during neonatal cardiopulmonary bypass surgery. Thromb Haemost. 2018;118:1545–55.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat McEwan A. Aspects of bleeding after cardiac surgery in children. Paediatr Anaesth. 2007;17:1126–33.PubMedCrossRef McEwan A. Aspects of bleeding after cardiac surgery in children. Paediatr Anaesth. 2007;17:1126–33.PubMedCrossRef
63.
Zurück zum Zitat Reverdiau-Moalic P, Gruel Y, Delahousse B, Rupin A, Huart MC, Body G, et al. Comparative study of the fibrinolytic system in human fetuses and in pregnant women. Thromb Res. 1991;61:489–99.PubMedCrossRef Reverdiau-Moalic P, Gruel Y, Delahousse B, Rupin A, Huart MC, Body G, et al. Comparative study of the fibrinolytic system in human fetuses and in pregnant women. Thromb Res. 1991;61:489–99.PubMedCrossRef
64.
Zurück zum Zitat Koh SC, Cheong YC, Arulkumaran S, Ratnam SS. Coagulation activation, fibrinolysis and inhibitors in neonates. Ann Acad Med Singap. 1997;26:767–71.PubMed Koh SC, Cheong YC, Arulkumaran S, Ratnam SS. Coagulation activation, fibrinolysis and inhibitors in neonates. Ann Acad Med Singap. 1997;26:767–71.PubMed
65.
Zurück zum Zitat Blanchette VS, Rand ML. Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol. 1997;21:53–62.PubMedCrossRef Blanchette VS, Rand ML. Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol. 1997;21:53–62.PubMedCrossRef
66.
Zurück zum Zitat Deschmann E, Sola-Visner M, Saxonhouse MA. Primary hemostasis in neonates with thrombocytopenia. J Pediatr. 2014;164:167–72.PubMedCrossRef Deschmann E, Sola-Visner M, Saxonhouse MA. Primary hemostasis in neonates with thrombocytopenia. J Pediatr. 2014;164:167–72.PubMedCrossRef
67.
Zurück zum Zitat Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med. 1998;158:470–6.PubMedCrossRef Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med. 1998;158:470–6.PubMedCrossRef
68.
Zurück zum Zitat Levin EG, Banka CL, Parry GC. Progressive and transient expression of tissue plasminogen activator during fetal development. Arterioscler Thromb Vasc Biol. 2000;20:1668–74.PubMedCrossRef Levin EG, Banka CL, Parry GC. Progressive and transient expression of tissue plasminogen activator during fetal development. Arterioscler Thromb Vasc Biol. 2000;20:1668–74.PubMedCrossRef
69.
Zurück zum Zitat Sumi Y, Dent MA, Owen DE, Seeley PJ, Morris RJ. The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. Development. 1992;116:625–37.PubMedCrossRef Sumi Y, Dent MA, Owen DE, Seeley PJ, Morris RJ. The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. Development. 1992;116:625–37.PubMedCrossRef
Metadaten
Titel
Developmental hemostasis in the neonatal period
verfasst von
Vicente Rey y Formoso
Ricardo Barreto Mota
Henrique Soares
Publikationsdatum
04.01.2022
Verlag
Springer Singapore
Erschienen in
World Journal of Pediatrics / Ausgabe 1/2022
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-021-00492-3

Weitere Artikel der Ausgabe 1/2022

World Journal of Pediatrics 1/2022 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Durch übermäßige Internetnutzung wird oft die Schule verpasst

Häufige Fehlzeiten in der Schule können durch physische und psychische Probleme verursacht werden. Wie in einer Studie aus Finnland nun belegt wird, führt auch die exzessive Nutzung des Internets gehäuft zu Abwesenheiten.

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.